ALERE BINAXNOW INFLUENZA A & B CARD 2: payments to doctors
Payments that named ALERE BINAXNOW INFLUENZA A & B CARD 2 as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Abbott?
Abbott reported the most payments naming ALERE BINAXNOW INFLUENZA A & B CARD 2. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $19K
- Providers
- 13
- Transactions
- 15
- Average per transaction
- $1,236
The per-transaction average — $1,236 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13 providers the average total is $1,427, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Abbott | $18,545 | 100.0% |
Other products from Abbott
The company that reported the most payments naming ALERE BINAXNOW INFLUENZA A & B CARD 2 also reports against these.
- PROCLAIM$14,811,931
- MitraClip$9,886,390
- FREESTYLE LIBRE 3$9,531,015
- AVEIR$8,443,593
- AMPLATZER AMULET$8,425,850
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$7,557,545
- CARDIOMEMS$6,528,879
- ENSITE PRECISION$5,038,193
- ENSITE$4,842,840
- Supera peripheral stent system$4,838,270